Overview

PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy of TARGIN administration as an analgesic to Korean patients treated with opioid analgesics for moderate-to-severe cancer pain under conditions of daily practice.
Phase:
Phase 4
Details
Lead Sponsor:
Mundipharma Korea Ltd
Treatments:
Naloxone
Oxycodone